BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 24, 2014
View Archived Issues
Novartis releases progress report from second quarter 2014
Read More
Vernalis and Tris Pharma achieve proof-of-concept for CCP-08
Read More
MRC Technology humanizes anti-tau monoclonal antibody for Axon Neuroscience
Read More
Epistem enters into collaborative funding agreement with GHIF for Genedrive platform and TB assay
Read More
Polaris Pharmaceuticals' ADI-PEG 20 obtains orphan drug status for mesothelioma
Read More
AOP Orphan conducting new trial in polycythemia vera
Read More
Biosceptre reports phase I results for BIL-010t in basal cell carcinoma
Read More
Advaxis and MedImmune partner on immunotherapy combination trial
Read More
Medigene's Trianta becomes project partner in German T-cell therapy collaborative research center
Read More
MODERN study of maraviroc regimen in HIV-1 infection does not meet primary endpoint
Read More
Alpharmagen describes novel alpha7-nAChR agonist
Read More
BioComo and Mie University present new hPIV2 vector-based vaccines
Read More
Puma reports topline results from phase III study of PB-272 in extended adjuvant breast cancer
Read More
Antisense Therapeutics reports data from phase I trial of ATL-1102
Read More
Bispecific, chimeric antibody-like immunoadhesin neutralizes HIV in vitro
Read More
New glycopeptide antibiotics disclosed by Chinese scientists
Read More
Vernalis and Lundbeck jointly patent novel LRRK2 inhibitors
Read More
Phase I/II safety data of a combination of a tuberculosis vaccine and antiretroviral therapy
Read More
Roche patents novel CDK8/cyclin-C inhibitors for cancer
Read More
Novel sigma1-receptor ligands disclosed by Esteve
Read More
FDA approves Ryanodex for treatment of malignant hyperthermia
Read More
Resverlogix reports MACE data in patients with diabetes treated with RVX-2018
Read More
UCB reports topline phase III results for brivaracetam in epilepsy
Read More
FDA approves Zydelig for three B-cell blood cancers
Read More
Plegridy approved in the E.U. for multiple sclerosis
Read More